Who invested in NeuroGenetic Pharmaceuticals?
NeuroGenetic Pharmaceuticals's investors include Novartis Venture Fund, Alta Partners, Advent International, S.R. One , Limited and Abbott Biotech Ventures, and 1 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$14Mraised across 7 rounds since 2002, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $50K sold, first sale Feb 2015
No investor was named in the report.
From a historical funding recordSEC filing: $100K sold, first sale Dec 2013
No investor was named in the report.
Reported by sec.govSEC filing: $250K sold, first sale Sept 2012
Reported by finsmes.comSEC filing: $500K sold, first sale Dec 2011
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Jun 2010
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
NeuroGenetic Pharmaceuticals's investors include Novartis Venture Fund, Alta Partners, Advent International, S.R. One , Limited and Abbott Biotech Ventures, and 1 more on record.
NeuroGenetic Pharmaceuticals has raised $14M across 7 rounds since 2002. One round did not disclose an amount, so the total is a floor.
NeuroGenetic Pharmaceuticals's most recent round was a Grant of $2.5M in Nov 2015.
NeuroGenetic Pharmaceuticals's largest round on record is $10M (Series B), in Nov 2002.
NeuroGenetic Pharmaceuticals's first round on record, in Nov 2002, was backed by Novartis Venture Fund, Alta Partners and Advent International and 2 others.
NeuroGenetic Pharmaceuticals's latest named round is a Grant, in Nov 2015.
NeuroGenetic Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.